KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Intangibles (2016 - 2025)

Historic Intangibles for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to $19.1 billion.

  • Bristol Myers Squibb's Intangibles fell 1803.75% to $19.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $19.1 billion, marking a year-over-year decrease of 1803.75%. This contributed to the annual value of $19.1 billion for FY2025, which is 1803.75% down from last year.
  • Latest data reveals that Bristol Myers Squibb reported Intangibles of $19.1 billion as of Q4 2025, which was down 1803.75% from $20.5 billion recorded in Q3 2025.
  • Over the past 5 years, Bristol Myers Squibb's Intangibles peaked at $50.8 billion during Q1 2021, and registered a low of $19.1 billion during Q4 2025.
  • Moreover, its 5-year median value for Intangibles was $32.0 billion (2023), whereas its average is $32.7 billion.
  • Its Intangibles has fluctuated over the past 5 years, first plummeted by 241.0% in 2024, then plummeted by 3136.14% in 2025.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Intangibles stood at $42.5 billion in 2021, then decreased by 15.68% to $35.9 billion in 2022, then decreased by 24.5% to $27.1 billion in 2023, then decreased by 13.91% to $23.3 billion in 2024, then decreased by 18.04% to $19.1 billion in 2025.
  • Its Intangibles stands at $19.1 billion for Q4 2025, versus $20.5 billion for Q3 2025 and $21.4 billion for Q2 2025.